A giant variant of acquired reactive perforating collagenosis

2021 ◽  
Author(s):  
Nao Kusutani ◽  
Sakurako Arai ◽  
Akiko Imanishi ◽  
Naoki Maekawa ◽  
Kazuyoshi Fukai
Keyword(s):  
Reactive Perforating Collagenosis

Reactive Perforating Collagenosis

1979 ◽  
Vol 41 (1) ◽  
pp. 41-45 ◽  
Author(s):  
Hiroshi MACHINO ◽  
Tomoyuki KAWATSU ◽  
Yoshiharu MIKI
Keyword(s):  
Reactive Perforating Collagenosis

scholarly journals Necrotic plaques in an elderly male

JRSM Open ◽  
2021 ◽  
Vol 12 (2) ◽  
pp. 205427042098145
Author(s):  
Bindi Gaglani ◽  
Ian Logan ◽  
Faris Kubba
Keyword(s):  
Diabetes Mellitus ◽  
Genetic Predisposition ◽  
Unusual Case ◽  
Renal Diseases ◽  
Elderly Male ◽  
Unusual Form ◽  
Underlying Diseases ◽  
Reactive Perforating Collagenosis ◽  
Giant Form

Reactive perforating collagenosis is commonly recognised as an unusual form of transepithelial elimination of collagen and elastin fibres which are extruded through the epidermis in patients with a genetic predisposition or underlying diseases, such as diabetes mellitus or renal diseases. We present the unusual case of an 87-year-old diabetic male with a giant form of reactive perforating collagenosis and review the available literature.

scholarly journals Successful treatment of acquired reactive perforating collagenosis with itraconazole

2021 ◽  
Vol 26 (1) ◽  
Author(s):  
Binrong Ye ◽  
Yi Cao ◽  
Yeqiang Liu
Keyword(s):  
Skin Biopsy ◽  
Fungal Infection ◽  
Successful Treatment ◽  
Rare Form ◽  
Case Presentation ◽  
Therapeutic Benefits ◽  
Immunological Tests ◽  
Anti Inflammatory ◽  
Reactive Perforating Collagenosis

Abstract Background Acquired reactive perforating collagenosis (ARPC) is a rare form of transepithelial elimination in which altered collagen is extruded through the epidermis. Case presentation A 23-year-old male presented with cup-like ulcerated lesions on his limbs since 3 months. A series of serological and immunological tests showed no abnormalities. A diagnosis of ARPC was based on skin biopsy findings. The patient was cured using treatment with itraconazole for 8 weeks, in the absence of a fungal infection. Conclusions The anti-inflammatory and anti-angiogenic effects of itraconazole can have good therapeutic benefits for ARPC.

Reactive perforating collagenosis

1985 ◽  
Vol 113 (s29) ◽  
pp. 44-45
Author(s):  
E. Young ◽  
F. Wojnarowska ◽  
P. Millard
Keyword(s):  
Reactive Perforating Collagenosis

scholarly journals Reactive perforating collagenosis

2016 ◽  
Vol 7 (2) ◽  
pp. 139 ◽  
Author(s):  
Sandeep Arora ◽  
Ajay Malik ◽  
Anil Balki
Keyword(s):  
Reactive Perforating Collagenosis

scholarly journals Case of acquired reactive perforating collagenosis induced by panitumumab for colon cancer

2020 ◽  
Author(s):  
Keita Tsutsui ◽  
Kenjiro Namikawa ◽  
Taisuke Mori ◽  
Ken Kato ◽  
Shunichi Jinnai ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Reactive Perforating Collagenosis

Post-varicella reactive perforating collagenosis arising as Wolf's isotopic response

2014 ◽  
Vol 24 (4) ◽  
pp. 497-498
Author(s):  
Hidetsugu Fukuda ◽  
Rie Kamo ◽  
Yuki Yokouchi ◽  
Hideki Mukai
Keyword(s):  
Reactive Perforating Collagenosis

Acquired Reactive Perforating Collagenosis

2020 ◽  
Vol 24 (11) ◽  
pp. 1086-1087
Author(s):  
Namrata Singhania ◽  
Girish Singhania ◽  
Laith Al-Rabadi
Keyword(s):  
Reactive Perforating Collagenosis
Sign in / Sign up

Export Citation Format

Share Document